Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''.

Samantha Bowyer,Prashanth Prithviraj,Paul Lorigan,James Larkin,Grant McArthur,Victoria Atkinson,Michael Millward, Muoi Khou,Stefan Diem,Sangeetha Ramanujam,Ben Kong,Elizabeth Liniker,Alexander Guminski,Phillip Parente,Miles C Andrews,Sagun Parakh,Jonathan Cebon,Georgina V Long,Matteo S Carlino,Oliver Klein

BRITISH JOURNAL OF CANCER（2017）

引用 1|浏览16

暂无评分

摘要

Reply to ‘Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy’’

查看译文

关键词

Adverse effects,Cancer immunotherapy,Clinical pharmacology,Melanoma,Biomedicine,general,Cancer Research,Epidemiology,Molecular Medicine,Oncology,Drug Resistance

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要